Abstract:
A super-resolution method for generating a high-resolution (HR) image from a low-resolution (LR) blurred image is provided. The method is based on a transform-invariant directional total variation (TI-DTV) approach with Schattenp=1/2 (S1/2-norm) and L1/2-norm penalties. The S1/2-norm and the L1/2-norm are used to induce a lower-rank component and a sparse component of the LR blurred image so as to determine an affine transform to be adopted in the TI-DTV approach. In particular, the affine transform is determined such that a weighted sum of the S1/2-norm and the L1/2-norm is substantially minimized. Based on the alternating direction method of multipliers (ADMM), an iterative algorithm is developed to determine the affine transform. The determined affine transform is used to transform a candidate HR image to a transformed image used in computing a directional total variation (DTV), which is involved in determining the HR image.
Abstract:
A method for enabling one or more nodes to communicate with an access point (AP) according to a CSMA/CA protocol is provided. In one embodiment of the method, when the individual node enters into a state of having at least one packet of data to be transmitted to the AP, the individual node waits for a non-zero deterministic delay so that any packet arrived during the delay is allowed to be aggregated and transmitted upon one transmission opportunity, thereby improving channel utilization. The delay is determined such that a predicted system throughput is maximized. It is found that the system throughput is significantly affected by the relationship between the delay and the number of the one or more nodes. Hence, the delay is advantageously determined according to the number of the one or more nodes. After the delay expires, the individual node initiates a contending procedure.
Abstract:
The present invention discloses a method of treating cancer comprising administering an effective amount of an alkaloid, in which the alkaloid is liensinine, isoliensinine, dauricine, cepharanthine, hernandezine or thalidezine and isolated from the traditional Chinese medicinal herbs. The use of the alkaloid in treating neurodegenerative disorder is also disclosed.
Abstract:
A super-resolution method for generating a high-resolution (HR) image from a low-resolution (LR) blurred image is provided. The method is based on a transform-invariant directional total variation (TI-DTV) approach with Schattenp=1/2 (S1/2-norm) and L1/2-norm penalties. The S1/2-norm and the L1/2-norm are used to induce a lower-rank component and a sparse component of the LR blurred image so as to determine an affine transform to be adopted in the TI-DTV approach. In particular, the affine transform is determined such that a weighted sum of the S1/2-norm and the L1/2-norm is substantially minimized. Based on the alternating direction method of multipliers (ADMM), an iterative algorithm is developed to determine the affine transform. The determined affine transform is used to transform a candidate HR image to a transformed image used in computing a directional total variation (DTV), which is involved in determining the HR image.
Abstract:
A compound suitable for treating cancer, in particular NSCLC, inhibits activity of oncogenic ROS1 kinase and ALK kinase. The compound has certain structural components such as a quinoline moiety in the backbone and at least one phenyl-containing moiety in a side chain with a hydrophobic substituent attached to the backbone via an up to 6-membered linking group as well as a further hydrophobic moiety. The presence of the structural components allows for an advantageous interaction with the ROS1 kinase domain and, further, with the ALK kinase domain. Hence, said compound represents a highly promising opportunity for patients bearing ROS1- or ALK-dependent cancer. A composition, in particular a pharmaceutical composition, includes the compound. A method for targeting cancer cells harboring an abnormality in ROS1 gene or ALK gene includes contacting a cell with the compound.
Abstract:
The present invention discloses that a method of treating cancer, preferably non-small cell lung cancer, comprises administrating mitoxantrone. The present invention also discloses a method of inhibiting ROS1 kinase comprising administrating mitoxantrone. A pharmaceutical composition comprising mitoxantrone is also disclosed.
Abstract:
A battery charger with power factor correction is provided. In particular, the battery charger is configured to work in a discontinuous current mode with a power factor that is almost unity but no bulky electrolytic capacitor is needed in the charger. The charger has a rectification circuit producing a rectified voltage to a first controllable switching circuit, whose output is fed to a series resonant tank series-connecting a first winding of a high-frequency transformer. The second winding thereof is connected to a second controllable switching circuit, whose output is a DC voltage for battery charging. The charger includes a control unit for generating a first control signal and a second control signal to control the first and the second controllable switching circuits, respectively, such that the current flowing in the first winding is substantially phase-aligned with the first control signal's waveform, thereby facilitating power factor correction.
Abstract:
The present invention relates to a method for authenticating age of longer-lived vascular plants based on microstructural data obtained either destructively or nondestructively and based on implementation of at least one model to determine growth-year of different cultivars.
Abstract:
An optical detection system for measuring a refractive index of a liquid analyte comprising a light transmitting assembly fiber, which includes a single-mode fiber, an optical fiber sensing module and a multi-mode fiber. The optical detection system is configured to emit a coherent light beam to one end of the assembly fiber; and a detector is configured to capture a specklegram from an exit end of the assembly fiber. When the optical detection system is in operation, the optical fiber sensing module is configured to be submerged into the liquid analyte. By analyzing the correlation between the specklegram corresponding to the liquid analyte and the reference specklegram, the refractive index of the liquid analyte can be obtained.
Abstract:
A battery charger with power factor correction is provided. In particular, the battery charger is configured to work in a discontinuous current mode with a power factor that is almost unity but no bulky electrolytic capacitor is needed in the charger. The charger has a rectification circuit producing a rectified voltage to a first controllable switching circuit, whose output is fed to a series resonant tank series-connecting a first winding of a high-frequency transformer. The second winding thereof is connected to a second controllable switching circuit, whose output is a DC voltage for battery charging. The charger includes a control unit for generating a first control signal and a second control signal to control the first and the second controllable switching circuits, respectively, such that the current flowing in the first winding is substantially phase-aligned with the first control signal's waveform, thereby facilitating power factor correction.